| 30. | EVENTS AFTER THE REPORTING PERIOD |
No event which is material to the understanding of this report has occurred between year-end and the date of the annual financial statements, other than: |
|
|
Cash dividend declaration The board of directors has decided, considering the current trading conditions and in order to preserve cash, not to declare or pay a final dividend for the year. |
|
|
Disposal of 100% of shares in Scanmed S.A The Group in November 2020 received an offer to dispose of its Polish operation, Scanmed to Abris Capital Partners, a central European private equity fund manager. The related agreements were signed on 24 November 2020 and the transaction is subject to regulatory approvals. The disposal consideration will be settled in cash and Life Healthcare will receive approximately PLN199 million (R806 million). The Group considered it prudent and appropriate to impair the carrying value at 30 September 2020 to reflect the fair value less costs to sell. The impairment for the year ended 30 September 2020, relating to Scanmed, is R793 million. |